Ginsenoside F1 administration promotes UCP1-dependent fat browning and ameliorates obesity-associated insulin resistance
Open Access
- 1 November 2023
- journal article
- research article
- Published by Tsinghua University Press in Food Science and Human Wellness
- Vol. 12 (6) , 2061-2072
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Synergism between cAMP and PPARSignalling in the Initiation of UCP1 Gene Expression in HIB1B Brown AdipocytesPPAR Research, 2013
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and SignalingCell Metabolism, 2012
- Reduction in insulin sensitivity following administration of the clinically used low‐dose pressor, norepinephrineDiabetes/Metabolism Research and Reviews, 2011
- Isolation and Characterization of a New Ginsenoside from the Fresh Root of Panax GinsengMolecules, 2010
- UCP1: its involvement and utility in obesityInternational Journal of Obesity, 2008
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocationAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Brown Adipose Tissue: Function and Physiological SignificancePhysiological Reviews, 2004
- Ginsenoside F1 Protects Human HaCaT Keratinocytes from Ultraviolet-B-Induced Apoptosis by Maintaining Constant Levels of Bcl-2Journal of Investigative Dermatology, 2003
- Hormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysisMetabolism, 1988